NCT07172919: An ongoing trial by Amgen
This trial is ongoing. It must report results 2 years, 6 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT07172919 |
|---|---|
| Title | A Rollover Study of Sotorasib With or Without Panitumumab for the Treatment of Cancer Subjects With KRAS p.G12C Mutation Previously Treated in an Amgen-Sponsored Study |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 2, 2026 |
| Completion date | Jan. 2, 2028 |
| Required reporting date | Jan. 1, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | June 9, 2026 |
| Days late | None |